Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. Refchem:153852
2. (2s,3s)-2-amino-3-methyl-n-(2-morpholinoethyl)pentanamide
3. 102562-74-3
4. 1243259-19-9
5. N-[2-(morpholin-4-yl)ethyl]-l-isoleucinamide
6. (2s,3s)-2-amino-3-methyl-n-(2-morpholin-4-ylethyl)pentanamide
7. Lm-11a-31
8. (2s,3s)-2-amino-3-methyl-n-[2-(4-morpholinyl)ethyl]pentanamide Hydrochloride
9. Y9guf3b7q7
10. Schembl1723692
11. Gtpl13391
12. Dtxsid50595097
13. Ynmutylwsrftpx-qwrguyrksa-n
14. Mfcd13245016
15. Bs-51733
16. Cs-0063684
17. F74058
18. (2s,3s)-2-amino-3-methyl-n-(2-morpholinoethyl) Pentanamide
19. (2s,3s)-2-amino-3-methyl-n-(2-morpholinoethyl)-pentanamide
20. Pentanamide, 2-amino-3-methyl-n-[2-(4-morpholinyl)ethyl]-, (2s,3s)-
| Molecular Weight | 243.35 g/mol |
|---|---|
| Molecular Formula | C12H25N3O2 |
| XLogP3 | 0 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 6 |
| Exact Mass | Da |
| Monoisotopic Mass | Da |
| Topological Polar Surface Area | 67.6 |
| Heavy Atom Count | 17 |
| Formal Charge | 0 |
| Complexity | 230 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
38
PharmaCompass offers a list of LM11A-31 API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right LM11A-31 manufacturer or LM11A-31 supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred LM11A-31 manufacturer or LM11A-31 supplier.
A LM11A-31 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of LM11A-31, including repackagers and relabelers. The FDA regulates LM11A-31 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. LM11A-31 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A LM11A-31 supplier is an individual or a company that provides LM11A-31 active pharmaceutical ingredient (API) or LM11A-31 finished formulations upon request. The LM11A-31 suppliers may include LM11A-31 API manufacturers, exporters, distributors and traders.
LM11A-31 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of LM11A-31 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right LM11A-31 GMP manufacturer or LM11A-31 GMP API supplier for your needs.
A LM11A-31 CoA (Certificate of Analysis) is a formal document that attests to LM11A-31's compliance with LM11A-31 specifications and serves as a tool for batch-level quality control.
LM11A-31 CoA mostly includes findings from lab analyses of a specific batch. For each LM11A-31 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
LM11A-31 may be tested according to a variety of international standards, such as European Pharmacopoeia (LM11A-31 EP), LM11A-31 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (LM11A-31 USP).
